Contineum Therapeutics

(NASDAQ) CTNM

Current Price$13.92

Market Cap$518.18M

Since IPO (2024)-10%

5 YearN/A

1 Year+254%

1 Month+7%

Contineum Therapeutics Financials at a Glance

Market Cap

$518.18M

Revenue (TTM)

$0.00

Net Income (TTM)

$58.44M

EPS (TTM)

$-1.95

P/E Ratio

-7.10

Dividend

$0.00

Beta (Volatility)

0.58 (Low)

Dividend

$0.00

Beta (Volatility)

0.58 (Low)

Price

$13.92

Volume

220,306.408

Open

$14.35

Price

$13.92

Volume

220,306.408

Open

$14.35

Previous Close

$13.86

Daily Range

$13.81 - $14.95

52-Week Range

$3.35 - $16.33

Dividend

$0.00

Beta (Volatility)

0.58 (Low)

Price

$13.92

Volume

220,306.408

Open

$14.35

Previous Close

$13.86

Daily Range

$13.81 - $14.95

52-Week Range

$3.35 - $16.33

CTNM News

Contineum (CTNM) Q2 R&D Jumps 78%

Motley Fool Markets TeamAug 5, 2025

CTNM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Contineum Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Carmine N. Stengone, MBA

Website

www.contineum-tx.com

Headquarters

San Diego, CA 92121, US

CTNM Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-27%

Return on Capital

-26%

Return on Assets

-22%

Earnings Yield

-14.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$518.18M

Shares Outstanding

37.39M

Volume

220.31K

Avg. Volume

273.38K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$68.06M

EBITDA

$67.74M

Operating Cash Flow

$55.31M

Capital Expenditure

$231.00K

Free Cash Flow

$55.54M

Cash & ST Invst.

$262.90M

Total Debt

$8.25M

Contineum Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$518.18M

N/A

Market Cap/Employee

$12.64M

N/A

Employees

N/A

Net Income

$14.46M

+9.6%

EBITDA

$16.90M

+6.3%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$239.37M

+29.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$4.65M

+2.3%

Short Term Debt

$2.30M

+58.3%

Return on Assets

-22.36%

N/A

Return on Invested Capital

-26.25%

N/A

Free Cash Flow

$16.58M

-14.7%

Operating Cash Flow

$16.27M

-12.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CADLCandel Therapeutics, Inc.

CADLCandel Therapeutics, Inc.$7.99+0.76%

LXEOLexeo Therapeutics, Inc. Common Stock

LXEOLexeo Therapeutics, Inc. Common Stock$5.11-2.29%

KYTXKyverna Therapeutics, Inc.

KYTXKyverna Therapeutics, Inc.$8.67-2.58%

AMRNAmarin Corporation plc

AMRNAmarin Corporation plc$14.43-0.82%

SLNSilence Therapeutics plc

SLNSilence Therapeutics plc$6.20-4.47%

ANROAlto Neuroscience, Inc.

ANROAlto Neuroscience, Inc.$21.22-1.49%

ACIUAC Immune S.A.

ACIUAC Immune S.A.$2.83-0.70%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$215.33-0.02%

NOKNokia

NOKNokia$15.47+0.09%

FFord Motor Company

FFord Motor Company$14.93+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

TET1 Energy Inc.

TET1 Energy Inc.$8.08-0.07%

FUTUFutu

FUTUFutu$89.76-0.28%

Questions About CTNM

What is the current price of Contineum Therapeutics?

Contineum Therapeutics is trading at $13.86 per share.

What is the 52-week range for Contineum Therapeutics?

Over the past 52 weeks, Contineum Therapeutics has traded between $3.35 and $16.33.

How much debt does Contineum Therapeutics have?

As of the most recent reporting period, Contineum Therapeutics reported total debt of $6.95M.

How much cash does Contineum Therapeutics have on hand?

Contineum Therapeutics reported $20.16M in cash and cash equivalents in its most recent financial results.

What is Contineum Therapeutics’s dividend yield?

Contineum Therapeutics does not currently have a dividend yield.

Contineum Therapeutics

Contineum Therapeutics Financials at a Glance

CTNM News

Contineum (CTNM) Q2 R&D Jumps 78%

CTNM: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Contineum Therapeutics

CTNM Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Contineum Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CTNM

What is the current price of Contineum Therapeutics?

What is the 52-week range for Contineum Therapeutics?

How much debt does Contineum Therapeutics have?

How much cash does Contineum Therapeutics have on hand?

What is Contineum Therapeutics’s dividend yield?

Premium Investing Services